Ampicillin-resistant Haemophilus influenzae. 2. Therapeutic considerations

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Rising incidence of ampicillin-resistant Haemophilus influenzae presents significant clinical challenges.
• Haemophilus influenzae is a frequent cause of both pediatric and adult infections.

Purpose of the Study:

• To address the clinical implications of ampicillin resistance in Haemophilus influenzae.
• To reevaluate current treatment strategies for H. influenzae infections, including otitis media and serious systemic diseases.

Main Methods:

• Literature review and analysis of clinical implications.
• Discussion of alternative antibiotic therapies based on susceptibility testing.

Main Results:

• Ampicillin is no longer the first-line empirical treatment for life-threatening H. influenzae infections.
• Chloramphenicol is a viable option for severe infections like meningitis.
• Alternative antibiotics for otitis media include trimethoprim-sulfamethoxazole, erythromycin-sulfonamide, and cefaclor.

Conclusions:

• Treatment protocols for H. influenzae infections must adapt to increasing ampicillin resistance.
• Susceptibility testing is crucial for guiding appropriate antibiotic selection.
• Reconsideration of empiric otitis media treatment is necessary.